WORTZMAN MITCHELL S 4
4 · MEDICIS PHARMACEUTICAL CORP · Filed Oct 17, 2012
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2012-10-15$43.39/sh−11,500$499,025→ 237,158 total
Footnotes (1)
- [F1]Trades were made pursuant to a Rule 10b5-1 trading plan entered into on August 17, 2012. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.38 to $43.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.